PhD Toni Petan

PhD Toni Petan
no.: 20213 source: ARIS

researcher – active in research organisation
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • Croatian
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • Macedonian
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • French
  • Reading: Fluent
  • Writing: Functional
  • Speaking: Functional
  • Spanish
  • Reading: Basic
  • Writing: Basic
  • Speaking: Basic
Edit
Research activity

Code Science Field Subfield
1.05.00  Natural sciences and mathematics  Biochemistry and molecular biology   
3.00.00  Medical sciences     
Keywords
Biochemistry, Molecular biology, genetic engineering, protein engineering, molecular cloning, phospholipases A2
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
379.4
A''
58.69
A'
281.96
A1/2
323.38
CI10
1,468
CImax
289
h10
16
A1
1.46
A3
0.02
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2022, 2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 41  1,599  1,416  34.54 
Scopus 41  1,698  1,511  36.85 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Špela Koren   Bologna doctoral studies    55063 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  Jožef Stefan Institute  Odsek za molekularne in biomedicinske znanosti (Slovene) 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J2-3040  Magnetically-controllable nanocarriers mimicking endogenous lipid particles for improved drug/nanoparticle delivery   10/1/2021 - 9/30/2025  PhD Darko Makovec   4,160 
2. L4-3181  Hierarchical DNA assembly for advanced applications in biopharmaceuticals production and cell therapy   10/1/2021 - 9/30/2024  PhD Marko Dolinar   1,754 
3. J1-2475  Development of an innovative drug to treat venous thromboembolism based on a unique viper venom anticoagulant   9/1/2020 - 8/31/2024  PhD Igor Križaj   2,101 
4. J3-2521  Inflammatory process in interstitial cystitis and evaluation of the influence of cannabinoid receptor agonists in urinary bladder - from cells to patients   9/1/2020 - 8/31/2023  PhD Peter Veranič   4,076 
5. J3-2534  Reversibility of transient thrombocytopenia induced by a snake venom component offers a safe antithrombotic prevention in interventional angiology and cardiology   9/1/2020 - 8/31/2023  PhD Miran Brvar   2,751 
6. L4-1839  Development of medical chestnut honey quality control and technology   7/1/2019 - 3/31/2023  PhD Janko Božič   4,661 
7. J7-1818  Targeting lipid droplets to reduce cancer cell resistance to stress   7/1/2019 - 6/30/2022  PhD Toni Petan   3,177 
8. N1-0047  Bisphenol A alternatives: transfer from food contact material, fate and human exposure   7/1/2016 - 6/30/2020  PhD Ester Heath   1,164 
9. J2-8166  Anizotropni magnetni nanodelci za magneto-mehansko zdravljenje raka (Slovene)   5/1/2017 - 4/30/2020  PhD Darko Makovec   4,687 
10. L1-7544  Improved treatment and monitoring of Water Framework Directive priority pollutants   3/1/2016 - 2/28/2019  PhD Ester Heath   7,858 
11. J3-4100  Odkrivanje inovativnih učinkovin za regulacijo hemostaze z venomiko kače Vipera a. ammodytes (Slovene)   7/1/2011 - 6/30/2014  PhD Igor Križaj   2,276 
12. J3-4168  Patogenomika in sistemska biologija novih virulenčnih faktorjev pri patogenih bakterijah (Slovene)   7/1/2011 - 6/30/2014  PhD Dušan Kordiš   2,250 
13. J3-0389  Proteins of the long-nosed viper venom acting on haemostasis – development of innovative biomedical antitrombotics.   2/1/2008 - 1/30/2011  PhD Igor Križaj   1,136 
14. J3-0386  The role of secretory phospholipases A2 in breast cancer   2/1/2008 - 1/30/2011  PhD Jože Pungerčar   1,105 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0207  Toxins and Biomembranes   1/1/2020 - 12/31/2027 PhD Igor Križaj   4,848 
2. P1-0207  Toxins and Biomembranes   1/1/2015 - 12/31/2019 PhD Igor Križaj   5,133 
3. P1-0207  Toxins and Biomembranes   1/1/2009 - 12/31/2014 PhD Igor Križaj   4,964 
4. P1-0207  Toxins and Biomembranes   1/1/2004 - 12/31/2008 PhD Igor Križaj   4,864 
5. P0-0501-0106  Toxinology   1/1/1999 - 12/31/2003 PhD Franc Gubenšek   2,482 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite